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Plant species typically store reduced carbon in the glucan polymer amylopectin, located in semicrystalline, insoluble starch granules. Amylopectin has the same chemical nature as glycogen, the soluble glucan storage polymer present in most nonplant species. Glc residues in both polymers are linked in linear chains by a-(1/4) glycoside bonds, and these are joined by a-(1/6) glycoside bonds referred to as branch linkages. Amylopectin and glycogen differ in molecular architecture, however, with regard to branch frequency and the relative positions of the a-(1/6) bonds. Branch linkages of amylopectin are located in clusters relatively close to one another compared to the longer interbranch distances of glycogen (Thompson, 2000) . Also, the branch frequency is lower in amylopectin than glycogen. These architectural features likely allow amylopectin crystallization and thus explain the different physical properties of starch and glycogen.
The chemical structures of amylopectin and glycogen are produced by the same classes of enzyme, specifically a glucan synthase that transfers Glc residues to a growing linear chain from a nucleotide sugar donor and a glucan branching enzyme that cleaves a linear chain at a glycoside bond and transfers one portion of it to a C-6 hydroxyl. A possible explanation for the different molecular architecture of amylopectin compared to glycogen is that the plant enzymes inherently have distinct substrate specificities that determine their sites of action. Amylopectin biosynthesis, however, likely requires coordination among these enzymes in addition to their individual substrate specificities. In contrast to glycogen biosynthesis, which typically requires only one glycogen synthase and one branching enzyme, multiple classes of starch synthase (SS) and starch branching enzyme (BE) are present in starch-producing tissues. Individual SSs and BEs are conserved to a large extent in the plant kingdom, and genetic analyses indicate that in many instances the functions of each class are nonredundant (Myers et al., 2000; Nakamura, 2002; Ball and Morell, 2003; James et al., 2003; Zhang et al., 2004 Zhang et al., , 2005 Delvalle et al., 2005; Fujita et al., 2007) . Another distinguishing feature of amylopectin biosynthesis is that a-(1/6) glucan hydrolase activity, i.e. starch debranching enzyme, is required for wild-type starch levels and for normal amylopectin structure (Ball et al., 1996; Myers et al., 2000; Ball and Morell, 2003) . No such function has been implicated in glycogen biosynthesis. Little is known regarding how the activities of so many enzymes capable of covalently modifying glucan polymers are coordinated to achieve the crystallization competent structure of amylopectin.
Longstanding genetic evidence suggests that starch biosynthetic enzyme activities are coordinated as opposed to acting independently through stochastic mechanisms. A classical example is the maize (Zea mays) gene dull1 (du1) that codes for SSIII (Gao et al., 1998) . The du1 gene was identified originally by mutant alleles that act as second-site genetic modifiers of a specific mutation of the gene sugary1 (su1; Mangelsdorf, 1947) , which codes for the starch debranching enzyme isoform ISA1 (James et al., 1995) . Neither the du1 2 mutation nor the su1 2 mutation have appreciable affects on kernel phenotype; however, when they are coupled in double homozygous mutants, there is a severe defect in starch biosynthesis that can be easily tracked genetically (Mangelsdorf, 1947) . The fact that the mutant phenotypes are not additive suggests that SSIII and ISA1 function via a concerted mechanism as opposed to catalyzing independent steps in starch biosynthesis. Genetic evidence also indicates that numerous starch biosynthetic enzymes depend on other components of the pathway for their activity. For example, mutation of SSIII affects the enzymatic activity of both BEIIa and SSI, in the former instance reducing activity and in the latter causing an increase in enzyme activity observed in cell extracts (Boyer and Preiss, 1981; Singletary et al., 1997; Cao et al., 1999) .
A hypothesis to explain these genetic interactions, as well as the organized architecture of amylopectin with regard to branch placement and frequency, is that the enzymes associate in one or more complexes. Such an arrangement would afford the possibility of coordinate and possibly reciprocal regulation and also might affect amylopectin architecture owing to spatial relationships between active sites. Consistent with this hypothesis, stable complexes between enzymes of the starch biosynthetic pathway were demonstrated in wheat (Triticum aestivum) endosperm extracts by immunoprecipitation . Specifically, BEIIb, BEI, and starch phosphorylase associated in a precipitable complex that requires Ser phosphorylation for stability. Further evidence from wheat endosperm is presented in the accompanying manuscript showing that trimeric complexes can be formed between SSI, SSII, and either of BEIIa or BEIIb (Tetlow et al., 2008) .
This study took a systematic approach to investigate the ability of SSs and BEs from developing maize endosperm to associate in multisubunit complexes.
Initial studies using in vivo protein-protein interaction tests revealed many interactions between distinct enzymes of the pathway that were sufficiently stable to reconstitute activity of the GAL4 reporter protein in yeast (Saccharomyces cerevisiae) nuclei. Biochemical analyses using immunoprecipitation and affinity purification methods demonstrated directly that multiple components of the pathway are capable of forming stable complexes. Interactions were observed involving SSI, SSIIa, SSIII, BEI, BEIIa, and BEIIb. In addition, many of these proteins comigrate in high molecular mass peaks in gel permeation chromatography (GPC), centered at either 600 or 300 kD. These observations of specific associations in cell extracts support the hypothesis that starch biosynthetic enzymes are physically coordinated in vivo.
RESULTS

In Vivo Protein-Protein Interaction Tests
Various maize endosperm starch biosynthetic enzymes were examined for their ability to form stable complexes using directed in vivo protein-protein interaction tests (Chien et al., 1991) . Data are reported here for the SS isoforms SSI and SSIII, and the BE isoforms BEI, BEIIa, and BEIIb. With the exception of SSIII, the polypeptides tested were the full-length mature proteins lacking the plastid targeting sequence. For SSIII, four fragments were tested, comprising residues 1 to 181, residues 1 to 367, residues 366 to 648, or residues 760 to 1,438 of the full-length protein. All of these segments of SSIII are located in the long N-terminal extension, distinct from the catalytic structure formed by the C-terminal portion of the polypeptide (Gao et al., 1998) . Each polypeptide was fused separately to both the activation domain and the DNA binding domain of the yeast transcriptional activator GAL4, referred to as GAL4-AD and GAL4-BD, respectively (Chien et al., 1991) . Empty vectors expressing GAL4-AD or GAL4-BD, but lacking any exogenous cDNA fusion, were utilized as negative controls. Positive controls were provided by fusions including the SV40 large T antigen or mouse p53, which in combination yield a very strong signal in this system (Li and Fields, 1993) .
Plasmids were cotransformed into yeast such that each protein pair was tested reciprocally with respect to which polypeptide was fused to GAL4-AD or GAL4-BD. In addition, each gene fusion plasmid was combined with the reciprocal negative control empty plasmid, and some were also tested with the SV40 and p53 positive controls. Results from the test matrix are presented in Table I , and sample data are shown in Figure 1 . The yeast host strain PJ69-4A contains as reporter genes the ADE2 and HIS3 prototrophic markers, as well as the Escherichia coli gene lacZ coding for b-galactosidase, in engineered forms that require reconstituted GAL4 activity for expression . All notations of positive signals in Table I indicate that the transformant grew on minimal medium lacking Ade and also generated obvious blue coloration in the filter lift assay that indicates cleavage of the substrate 5-bromo-4-chloro-3-indolyl-b-D-galactoside by b-galactosidase. The ADE2 reporter is known to be particularly stringent as a genetic marker in this system. Table II lists the positive pairwise interactions that were detected in the yeast system. Each of the maize peptide sequences tested was shown to be functional to regenerate GAL4 activity in at least one instance, and none of them activated the reporter genes when combined with the reciprocal, empty AD or BD plasmid. These results indicate the in vivo test detected specific protein-protein interactions. One reciprocal set of positive interactions was observed, specifically BEIIa with SSIII . All of the other positive interactions were unidirectional, i.e. they occurred only with one of the two possible combinations of GAL4-AD and GAL4-BD fusions. Self-binding was evident for BEIIa, SSIII , and SSI. Two separate regions of SSIII interact with full-length SSI in the in vivo interaction test, specifically residues 1 to 367 and residues 760 to 1,438 (Fig. 2) . The latter region, referred to as SSIIIHDX, comprises all of the evolutionarily conserved sequence specific to SSIII isoforms located in residues 769 to 1,226 (Abel et al., 1996; Marshall et al., 1996; Gao et al., 1998; Li et al., 2000 Li et al., , 2003 . Similarly, the in vivo test indicated that BEIIa is capable of binding to two distinct spans of amino acids in the unique N terminus of SSIII, specifically 1 to 181 and 366 to 648 (Fig. 2) .
Development of Antisera for Recognition of Maize Endosperm SSs and BEs
Polyclonal antisera raised against recombinant protein or synthetic peptides were developed as reagents for recognition of BEI, BEIIa, BEIIb, SSI, SSIIa, or SSIII from maize endosperm. Genetic tests to verify the specificity of each antiserum made use of mutations in the genes ae (Stinard et al., 1993) , sbe2a (Blauth et al., 2001) , sbe1 (Blauth et al., 2002) , su2 (Zhang et al., 2004) , and du1 (Gao et al., 1998) , which code for BEIIb, BEIIa, BEI, SSIIa, or SSIII, respectively.
The serum designated aBEIIa/b was raised using full-length recombinant BEIIa as the antigen. This serum detects two major protein bands in wild-type endosperm soluble extracts, with apparent molecular mass of approximately 90 kD or 75 kD (Fig. 3A , Figure 1 . In vivo protein-protein interaction between SSIIIHDX and SSI. The indicated combinations of gene fusions containing either the GAL4 transcriptional activation domain (AD) or the GAL4 DNA binding domain (BD) were cotransformed into yeast reporter strain PJ69-4A. Single colony-purified transformants were patched on 2Ade selective medium to test for activation of the ADE2 reporter gene or on minimal selective medium for filter lifts and b-galactoside assays after cell permeabilization to test for activation of the lacZ reporter gene. p53 and SV40 large T antigen (LTA) are well-documented positive controls for this system. SSIII in all instances represents the fragment SSIIIHDX comprising residues 760 to 1,438.
Table I. In vivo protein-protein interaction test results
The indicated GAL4-BD and GAL4-AD fusion plasmids were cotransformed into yeast strain PJ69-4A. 1, Growth on minimal medium lacking Ade and blue color in the b-galactosidase assay. At least four independent transformants were tested for each pair. n.d., Data for the indicated plasmid pair were not determined; None, negative control plasmids lacking any maize sequence. Positive controls p53 and SV40 large T antigen (LTA) are described in ''Materials and Methods. ' 
center). The protein generating the 90-kD signal is absent from sbe2a 2 mutant endosperm extracts (Fig.  3A, center) , and its apparent molecular mass matches the value predicted from the known cDNA sequence and mature amino terminus of BEIIa (Gao et al., 1997) . Another antiserum, designated aBEIIa, was raised using a BEIIa-specific synthetic peptide as the antigen. This serum also recognizes the 90-kD protein present in wild-type endosperm but fails to generate this signal in the sbe2a 2 mutant (Fig. 3B, top right ). These data demonstrate conclusively that both aBEIIa/b and aBEIIa recognize BEIIa in immunoblots.
Similar analyses demonstrated that aBEIIa/b and the anti-peptide antiserum aBEIIb both react with BEIIb and also that the latter antiserum is specific for that particular branching enzyme. A 75-kD signal is detected by both antisera. This signal is significantly reduced in analysis of an ae 2 point mutant probed with aBEIIa/b (Fig. 3A, center) and is missing in analysis of an ae 2 null mutation probed with either aBEIIb (Fig.  3B, top left) or aBEIIa/b (data not shown). The aBEIIb serum did not generate the 90-kD signal identified as BEIIa, indicating that it is isoform-specific (Fig. 3B, top  left) . The 75-kD signal identified in the gels shown in Figure 3 as BEIIb is less than the 85-kD size predicted by the cDNA sequence coding for the mature protein (Fisher et al., 1993) . In a different SDS-PAGE gel system, however, the protein recognized by aBEIIb runs at an apparent molecular mass of 85 kD (see Fig. 6A ). Thus, BEIIb appears to migrate anomalously in standard Laemmli conditions for SDS-PAGE.
The antipeptide sera aBEI and aBEIg both detect a protein of approximately 80 kD in wild-type endosperm extracts as well as in the BEIIa-and BEIIbdeficient mutants ( Fig. 3A, left; data not shown). The 80-kD protein is absent in the sbe1 2 mutant (Fig. 3A,  left) . The sequence of the maize BEI cDNA predicts a protein of approximately 86 kD after the plastid targeting peptide has been removed (Baba et al., 1991) , which is in general agreement with the observed mobility in SDS-PAGE. These data demonstrate that antibodies in the aBEI and aBEIg sera bind specifically to BEI and do not cross-react with either BEIIa or BEIIb.
The antipeptide serum aSSIIa identified a protein with an apparent molecular mass of approximately 75 kD that is absent from the su2 2 null mutant (Fig. 3B , bottom left). The apparent molecular mass of the signal matches the predicted value for mature SSIIa based on the cDNA sequence coding for the mature protein . These data indicate that aSSIIa effectively identifies SSIIa.
The antipeptide serum aSSIg recognized a protein with an apparent molecular mass of approximately 74 kD, as did the serum aSSI that was raised against recombinant SSI (see Figs. 5A and 6B) . This molecular mass is larger than the value predicted from the SSI cDNA; however, anomalous migration in SDS-PAGE is well documented for this particular protein (Mu et al., 1994; Knight et al., 1998) . SSI maize mutants are not available, so genetic analysis could not be used to verify the specificity of the aSSI and aSSIg antisera.
Two different antibody preparations were used for analysis of SSIII. The serum designated aDU1N, raised against the amino terminal 648 residues of the fulllength SSIII protein, has been previously described (Cao et al., 1999) . In addition, an affinity purified IgG fraction, designated aSSIIIHDP, was prepared to identify the central, conserved portion of SIII. This region, referred to as the SSIII-homology domain (SSIIIHD), comprises residues 770 to 1,226 in the maize protein (Gao et al., 1998) . SSIIIHD is entirely separate from the glucan synthase catalytic domain, but the sequence is highly conserved among SSIII homologs from dicots and monocots (Gao et al., 1998; Li et al., 2000) . The precise SSIIIHD region was expressed in E. coli, purified, coupled to a resin, and used as an affinity ligand to collect a fraction of the IgG molecules present in a BD-AD, Positive results were obtained when the first polypeptide listed was fused to GAL4-AD and the second polypeptide listed was fused to GAL4-BD, and further that the positive signal was not observed when reciprocal fusions were tested. BD-AD; AD-BD, Positive signals were obtained regardless of which polypeptide was fused to either of the GAL4 segments. Figure 2 . SSIII gene diagram. Numerals indicate the residue number of the SSIII full-length primary sequence. The black box indicates the region that is homologous to prokaryotic glycogen synthases and other a-(1/4) glucan synthases and thus contains the domains responsible for catalytic activity. The gray box indicates SSIIIHD, a region of sequence conserved specifically in SSIII proteins in both monocots and dicots. Arrows indicate the region of SSIII primary sequence that bound to full-length SSI in yeast nuclei, and asterisks indicate the location of peptide sequences identified from a 60-kD polypeptide purified on a SSI-affinity column (see Fig. 7 ). serum aDU1F (Cao et al., 1999) . The aDU1F serum was raised against full-length recombinant SSIII and thus is expected to contain antibodies that recognize epitopes within SSIIIHD. In immunoblot analyses of amyloplast extracts (Fig. 3C) or whole cell extracts (data not shown), aSSIIIHDP recognized a sharp band migrating in SDS-PAGE above the 200-kD molecular mass marker. This signal was not detected in analysis of amyloplasts purified from a du1-M3 mutant (Fig.  3C ), which contains a Mutator transposon insertion within the first exon of the SSIII coding sequence (M.G. James, unpublished data), thus demonstrating that the antibody effectively and specifically recognizes SSIII. The molecular mass predicted for full-length SSIII is approximately 180 kD (Gao et al., 1998) , which matches reasonably well, but not precisely, with the protein's observed mobility in SDS-PAGE. Upon longer exposure, the aSSIIIHDP immunoblot reveals a series of bands smaller than full-length SSIII (Fig. 3C) , which presumably are generated by proteolysis of the intact protein.
GPC Behavior of Maize Endosperm BEs and SSs
GPC was used to examine whether specific SSs and BEs fractionate in apparent high molecular mass complexes compared to the mass of the monomeric proteins. The starting fraction for this column was soluble lysate from partially purified amyloplast fractions obtained from either of two inbred lines, Oh43 or W64A, harvested 16 to 17 d after pollination (DAP). Column fractions were analyzed by immunoblot analyses using aBEIIa/b, aBEI, aBEIIa, aBEIIb, aSSIIa, or aSSIIIHDP as the probe. In standard phosphate buff- Figure 3 . Antibody specificity tested by immunoblot analysis. Soluble endosperm extracts from maize lines of the indicated genotype were separated by SDS-PAGE and subjected to immunoblot analyses using the indicated antibodies at dilutions of 1/1,000 or 1/2,000. Abbreviations for mutations are as follows: ae 2 , ae-1; ae°, ae-B; sbe1°, sbe1TMu; 2a°, sbe2aTMu; su2°, su2-19791; du1°, du1-M3. WT, Wild-type inbred maize line W64A; M, lanes containing molecular mass standards. A, Characterization of aBEI and aBEIIa/b. B, Characterization of aBEIIa, aBEIIb, and aSSII. C, Characterization of aSSIIIHDP. In C, both lanes were loaded with 20 mg of amyloplast-enriched soluble protein fraction.
ered saline buffer (PBS; 50 mM sodium phosphate buffer, pH 7.5, 150 mM NaCl), BEIIb appears in a broad distribution across the column elution. There is an obvious low molecular mass peak containing the majority of BEIIb (Fig. 4 , row 1, fractions C10-C12). Minor amounts of BEIIb are also detectable in high molecular mass fractions extending all the way to the 670-kD marker, which is the permeability limit for this column matrix (Fig. 4, row 1 ). Quantitatively different results were obtained when the GPC fractionation was performed in the presence of PBS containing 1 M NaCl instead of the standard concentration of 0.15 M NaCl (i.e. high salt conditions). In this instance, the abundance of BEIIb in the high molecular mass fractions increased significantly and exhibited a peak in fractions B4 to B6 at the elution volume corresponding to approximately 600 kD (Fig. 4 , row 2). Thus, high salt conditions appear to favor formation of a high molecular mass complex containing BEIIb.
Like BEIIb, BEIIa was also observed in a high molecular form(s) that is stabilized by high salt conditions. In standard PBS, the isoform-specific antiserum aBEIIa detected the great majority of BEIIa in a well-defined elution peak corresponding with its known molecular mass of approximately 90 kD (Gao et al., 1997; Fig. 4 , row 3, fractions C7-C11). In addition, minor amounts of BEIIa were detected in fractions extending to C1, corresponding to a molecular mass of approximately 300 kD (Fig. 4, row 3 ). In contrast, when the lysate was fractionated in the presence of 1 M NaCl, the minor population of BEIIa extended to fraction B6 at the elution volume of the 670-kD marker (Fig. 4 , row 4). Appreciable branching enzyme activity in fractions containing the low molecular mass proteins detected by aBIIa/b was indicated by biochemical assay (data not shown), providing further evidence for the assigned identities of these signals as BEIIa and BEIIb.
The same analysis applied to SSIIa again revealed a high molecular mass fraction and a monomer fraction, in this instance with the great majority of the protein in the apparently larger form. In standard PBS, the high molecular mass peak is centered around fraction C1, corresponding to approximately 300 kD, and this well-defined peak tails off at fraction B3 (Fig. 4 , row 5). This peak is also observed in high salt conditions, along with a second high molecular mass peak of SSIIa centered around fraction B5 at the elution volume corresponding to approximately 600 kD (Fig. 4 , row 6). Thus, BEIIa, BEIIb, and SSIIa all appear to share the property that high salt concentration favors their inclusion in a multimeric complex of approximately 600 kD.
Fractionation of SSIII on the GPC column was monitored using aSSIIIHDP. In standard PBS buffer, SSIII eluted in a discrete, high molecular mass peak corresponding to approximately 600 kD as judged by the elution position of the 670-kD molecular mass marker (Fig. 4 , row 7, fractions B3-B6). Long exposures of these immunoblots reveal minor amounts of SSIII extending to fraction C2 (data not shown), corresponding to approximately 200 kD and approximating the monomer molecular mass. Essentially similar results were observed when the analysis was performed in 1 M NaCl (data not shown).
The presence of BEI was also monitored throughout column elutions under both high and low salt GPC fractionation conditions. In both instances, the only form of BEI detected was a low molecular mass form, indicative of the monomer (Fig. 4 , row 8; data not shown). Thus, under these GPC conditions, BEI behaved differently than BEIIa, BEIIb, SSIIa, or SSIII in the regard that it was not detected in the high molecular mass fractions.
In summary, the GPC data suggest the existence of at least two distinct high molecular complexes that contain multiple starch biosynthetic enzymes. SSIIa fractionates in a well-resolved peak of approximately 300 kD (Fig. 4 , rows 5 and 6), designated here as ''C300.'' The same fractions also contain BEIIa and BEIIb (Fig. 4 , rows 1-4). A second apparent complex, referred to as ''C600,'' is defined by migration of the SSIII protein in a peak at about 600 kD (Fig. 4 , row 7). This same high molecular fraction peak also contains SSIIa, BEIIa, and BEIIb (Fig. 4 , rows 2, 4, and 6).
Formation of C600 appears to be favored by high salt conditions, represented here by 1 M NaCl. Further proteomic analysis will be required to define the nature of the complex(es) located in the C300 or C600 chromatography peaks. The specific elution behaviors of BEIIa, BEIIb, SSIIa, and SSIII, however, suggest that each of these proteins may be present in the same multisubunit complex. Whether or not SSI might also comigrate with the other starch biosynthetic enzymes could not be determined because the available antibodies were not effective in these conditions (data not shown).
Protein Interactions Detected Using Immobilized Recombinant Enzymes
Interacting Proteins from Whole Cell Extracts
Affinity purification with recombinant proteins immobilized on agarose beads was used as an additional method of detecting interactions among starch biosynthetic enzymes. An advantage of this technique is that the high concentration of the ligand in the solid phase can favor formation of complexes between proteins with relatively low binding affinity. The immobilized proteins, either BEIIa or SSI, were shown to be enzymatically active after binding to the matrix by biochemical assay (data not shown), indicating that natively folded protein is available for binding to potential partners in the cell extracts. Whole-cell soluble extracts from maize kernels were first passed through a column containing bound bovine serum albumin (BSA) to minimize nonspecific protein-protein binding interactions. The extracts were then applied to the immobilized affinity ligands in low salt conditions, specifically 0.1 M KCl. The columns were washed in low salt buffer until no further protein elution could be detected, and bound proteins were then eluted from the matrix in a step gradient of increasing salt concentration from 0.2 M to 1.0 M KCl. The eluted proteins were concentrated, separated by SDS-PAGE, and characterized by immunoblot analyses. Fractions from the column elution were subjected to SDS-PAGE and then immunoblot analyses. Labels on top of each column indicate the fraction, with earlier elution and larger molecular masses on the left. The GPC elution positions of molecular mass markers (Bio-Rad), as determined in independent column runs under identical conditions, are indicated by small vertical arrows. Horizontal arrows indicate molecular mass marker positions for SDS-PAGE. The antibody used for each immunoblot is indicated to the right of each segment, along with the maize inbred line used to prepare the amyloplasts and the salt condition.
Recombinant BEIIa was immobilized to S-protein agarose by means of an S-tag sequence fused at the amino terminus, and this matrix was used to isolate proteins from whole cell extracts of developing maize kernels. Immunoblot analysis using aSSI revealed that the SS bound to the BEIIa column and eluted in a specific peak in KCl concentrations of 0.2 M to 0.6 M (Fig. 5A ). This signal was not detected when the same analysis was applied using S-agarose beads without any maize protein attached (data not shown).
The reciprocal experiment was performed in which recombinant maize SSI was immobilized on S-protein agarose. Immunoblot analysis using aBEIIa/b revealed two proteins that bind to the SSI matrix and migrate in SDS-PAGE at the apparent molecular masses known to correspond to BEIIa and BEIIb (Fig. 5B) . Again, the bound protein eluted in a specific peak of salt concentration from 0.2 M to 0.6 M KCl. Thus, in both orientations in this affinity purification procedure, BEIIa and SSI were found to associate. In addition, an association between BEIIb and SSI was observed using the SSI affinity matrix.
Interacting Proteins from Amyloplast Extracts
Affinity purification with recombinant SSI or BEIIa as the immobilized ligand was also performed using maize amyloplast extracts. In these analyses, after application of the extract to the column, the beads were washed extensively in 0.15 M KCl to remove nonspecific interactions then boiled in SDS-PAGE loading buffer. Thus, all proteins attached to the affinity matrix were released in a single step, as opposed to the salt gradient elution employed for the whole kernel extracts. S-protein agarose beads without any bound recombinant protein were used as the negative control. The bound proteins were separated by SDS-PAGE and analyzed by immunoblot analyses using antisera that recognize SSI, SSIIa, BEIIb, BEIIa, or BEI.
Analysis of the proteins collected on the SSI affinity column verified the results obtained using whole cell extracts with regard to purification of BEIIb (Fig. 6A ) and BEIIa (data not shown). In addition, a signal for SSIIa was detected in the bound fraction by aSSIIa serum (Fig. 6A) . The BEIIa affinity column retained both SSI and SSIIa (Fig. 6B ), but no signal was observed in the eluate using aBEIIb as the immunoblot probe (data not shown). The affinity data taken together indicate the existence in these cell extracts of stable multisubunit complexes comprising SSI/SSIIa/ BEIIa and SSI/SSIIa/BEIIb.
Identification of Affinity Purified Proteins by Mass Spectrometry
Mass spectrometry determination of amino acid sequences from affinity purified proteins was used as a complement to immunological identification. In these experiments, amyloplast extracts were applied directly to S-agarose columns bearing SSI or BEIIa as the affinity ligand. Samples were applied in buffer containing 0.15 M NaCl, and the columns were washed extensively in the same buffer. Bound proteins were eluted with a step gradient of increasing KCl concentration, and the fractions from 0.6 M to 1.0 M from each column were pooled, desalted, and concentrated. These proteins were then separated by SDS-PAGE and visualized by staining with Sypro Ruby.
The SSI affinity matrix bound two major protein bands, one migrating at an apparent molecular mass of approximately 70 kD and the other at approximately 60 kD (Fig. 7) . Each band was excised from the agarose gel, digested with trypsin, and analyzed by electrospray tandem mass spectrometry. Two peptide sequences present in the 70-kD band matched precisely to sequences within maize BEIIa (GenBank accession no. AAB67316). Thus, BEIIa was again observed to bind to the SSI affinity column, in this instance eluting at a salt concentration that overlaps one in which it was identified immunologically. One of these two peptides is also identical in sequence to a segment of BEIIb (GenBank accession no. AAC33764), raising the possibility that BEIIb may also be present in this 70-kD band.
The 60-kD band from the SSI affinity column yielded two peptides that match precisely to sequences within maize SSIII (GenBank accession no. AAC14014). These data indicate that SSIII either binds directly to SSI or is part of a complex that contains SSI. The two peptides observed are located within the SSIIIHD portion of this class of SS (Fig. 2) . The location of the two peptides, approximately 50 kD apart in primary sequence, considered together with the 60-kD molecular mass of the SSIII fragment retained on the SSI affinity column, indicates that the purified fragment comprises most or all of the SSIIIHD region and little else from the SSIII primary sequence.
The BEIIa column purified four visible protein bands that migrated at apparent molecular mass between approximately 70 kD and 80 kD. These four bands were excised as a single group and analyzed by mass spectrometry. Among these proteins, one peptide sequence was identified that matches precisely to a sequence within maize SSI (GenBank accession no. AAB99957; Fig. 7) . Although a single peptide is not sufficient by itself to conclude that the protein is present, taken together with the immunological identifications, these data provide strong evidence that SSI is bound onto the BEIIa affinity matrix. The identities of the other three proteins bound to BEIIa could not be determined by the mass spectrometry analysis, probably owing to the low level of material present.
Further Analysis of SSIIIHD
The SSIII and BEIIa polypeptides purified on the SSI affinity column and identified by mass spectrometry reproducibly migrated in SDS-PAGE at apparent molecular masses less than that of the full-length protein. This is especially obvious for SSIII, because the purified polypeptide had an apparent molecular mass of 60 kD, whereas the full-length protein is approximately 180 kD. To test the authenticity of the SSI-SSIII interaction, immunoblot analysis was used to examine whether the 60-kD SSIIIHD fragment exists in the cell extract starting material applied to the SSI-affinity column. Use of the aSSIIIHDP IgG fraction allowed Figure 6 . Affinity chromatography using amyloplast extracts. Amyloplast extracts in low salt buffer were incubated with S-protein agarose attached to the indicated recombinant maize proteins or S-protein agarose without any recombinant protein attached (indicated by 2). After washing, the beads were boiled in SDS-PAGE sample buffer. Bound proteins were subjected to SDS-PAGE and immunoblot analyses using the indicated antisera. These SDS-PAGE gels were 4% to 12% acrylamide run using the NuPAGE buffer system. A, SSI affinity column. B. BEIIa affinity column. B2a indicates BEIIa. identification of intact SSIII or any subfragments that contain SSIIIHD. In addition to apparent full-length SSIII, a 60-kD signal was clearly observed in total amyloplast extracts (Fig. 3C ) and total endosperm cell extracts (data not shown). Thus, the fragment identified by peptide sequence is readily available in cell extracts.
In GPC analysis, the 60-kD SSIIIHD fragment was detected exclusively in the high molecular mass fraction C600 that also contains full-length SSIII, and none was observed in the fractions containing the SSIII monomeric form (Fig. 4, row 7) . The 60-kD fragment, therefore, is associated with a high molecular mass complex. At this point, it is not possible to distinguish whether some portion of SSIII is fragmented in the C600 complex in vivo, or if limited proteolysis occurs after cell lysis. Protease inhibitor cocktail was included in all extraction buffers so as to minimize post-lysis degradation; however, whether or not the inhibition was completely effective cannot be known.
Further validation of the interaction between SSIIIHD and SSI is provided by the results of the in vivo protein-protein interaction tests. As described previously, a fragment made up for the most part of the complete SSIIIHD sequence tested strongly positive for interaction with SSI in the two-hybrid test ( Fig. 1 ; Table I ).
Coimmunoprecipitation of Multiple SSs and BEs
Immunoprecipitation from Kernel Extracts
Coimmunoprecipitation was used as another approach to analyze potential binding partners of maize BEIIa, BEIIb, SSI, SSIIa, and SSIII. Protein-A Sepharose beads preincubated with aBEIIa/b serum effectively precipitated BEIIa from whole kernel extracts (Fig.  8A) . Little if any BEIIb was found in these eluted fractions. Thus, aBEIIa/b appears to be more effective at precipitating BEIIa than BEIIb, even though in immunoblot analysis the antiserum recognizes both proteins in total extracts (Figs. 3 and 8A) . The same procedure using preimmune serum did not result in any detectable BEIIa or BEIIb in the precipitate (Fig.  8A) . Thus, binding of any coprecipitating proteins to the immunoaffinity matrix depends on the presence of antibodies that recognize BEIIa. Probing the precipitate fractions with aSSI antiserum revealed an immunoblot signal of the size expected for the SSI protein (Fig. 8A) . The preimmune serum did not precipitate SSI (Fig. 8A) , again demonstrating that the apparent coprecipitation depends on antibodies that bind BEIIa.
In reciprocal experiments, aSSI was bound to protein A-Sepharose beads. As expected, SSI was detected when the resultant precipitated proteins were probed with aSSI (Fig. 8B) . Probing the precipitate with aBEIIa/b revealed a signal of the expected molecular mass for BEIIa and also a signal that corresponded to the expected mobility of BEIIb (Fig. 8B) . Thus, both BEIIa and BEIIb coprecipitate with SSI. The preimmune serum controls (Fig. 8A) indicate that the apparent coprecipitation of BEIIa and BEIIb depends on the presence of SSI.
The same approach was used to identify binding partners for SSIII. An antiserum termed aDU1N, which was raised against residues 1 to 648 of SSIII (Cao et al., 1999) , was preincubated with protein A-Sepharose. Those beads were then incubated with kernel extract, and the eluate was probed for the presence of BEIIa, BEIIb, and SSI. The results showed that SSI was precipitated by the aDU1N antiserum (Fig. 8B) . No signal was detected for BEIIa or BEIIb in the aDU1N precipitate using aBEIIa/b as the immunoblot probe (data not shown). This last result is contrast to the interactions between SSIII and the BEs observed by the in vivo interaction test, which might be explained by the capabilities of the particular antiserum used for immunoprecipitation.
Immunoprecipitation from Amyloplast Extracts
Immunoprecipitation was also performed using amyloplast extract as the starting material, with either aSSIg or aSSIIa as the precipitating serum. In these instances, the precipitates were boiled in SDS-PAGE sample buffer to release the precipitating antibodies and any bound proteins. The proteins were then separated by SDS-PAGE and analyzed by immunoblotting with various antisera. As expected, immunoprecipitation with aSSIg effectively collected SSI from the amyloplast extracts (Fig. 8C ). BEIIa and BEIIb were observed in the SSI coimmunoprecipitate (Fig. 8C) , as had been seen using whole cell extracts (Fig. 8B ). In addition, SSIIa and BEI were detected in the SSI coimmunoprecipitate by immunoblot analyses using aSSIIa or aBEIg serum (Fig. 8C) . Control precipitations using protein-A Sepharose without any bound antibodies did not yield any signals in the immunoblot analysis (data not shown).
Coimmunoprecipitation using aSSIIa as the precipitating agent was also performed. As expected, the aSSIIa serum effectively precipitated SSIIa (data not shown). In addition, SSI and BEIIb were also detected as coprecipitated proteins in the immunoblot analysis (Fig. 8D) .
DISCUSSION Multisubunit Complexes Containing Starch Biosynthetic Enzymes
The results of this study indicate that many of the starch biosynthetic enzymes in maize endosperm are capable of associating with each other, either directly or indirectly, in multisubunit complexes. The pairs of proteins that were observed by at least one analytical method to be present in the same complex are SSI/ SSIIa, SSI/SSIII, SSI/BEI, SSI/BEIIa, SSI/BEIIb, SSIIa/ BEIIa, SSIIa/BEIIb, and SSIII/BEIIa. Three different methods were employed to test these interactions, and many of the pairs were detected in multiple analyses (Table III) . The most frequently observed association was SSI with BEIIa, which was detected in both test orientations by immunoprecipitation and affinity purification and in one orientation of the in vivo proteinprotein interaction test. The association between SSI and SSIII was also observed by all three methods. Evidence for the SSI/SSIIa and SSI/BEIIb-containing complexes was obtained from both immunoprecipitation and affinity purification. The remaining associations were detected only by one analytical method, and further work is in progress to gather additional support that these proteins are in fact components of multisubunit complexes. In addition to the pairwise association data, GPC analyses directly demonstrated that some population of the SSIIa, SSIII, BEIIa, and BEIIb proteins assemble into one or more high molecular mass complexes. Taken together, this body of evidence demonstrates definitively that maize endosperm SSs and BEs are capable of forming stable multisubunit complexes.
A companion analysis addressing protein-protein interactions in wheat amyloplasts demonstrated that starch biosynthetic enzymes from that species are also capable of forming multisubunit complexes (Tetlow et al., 2008) . Complexes were detected that contained SSI, SSIIa, and either BEIIa or BEIIb. Thus, the ability of SSs and BEs to associate with each other is likely to be a conserved feature in endosperm cells and potentially in other starch-producing tissues.
The GPC analyses shown in this study suggest the existence of at least two distinct high molecular mass complexes. SSIIa, BEIIa, and BEIIb all migrate in GPC in the same high molecular mass fractions of approximately 300 kD, in the C300 peak (Fig. 4) . The presence of SSI in C300 could not be examined in this study for technical reasons, although given the pairwise association data, there is a strong possibility that SSI will also be found in the same fractions. SSIII is not present in C300, instead appearing only at a higher molecular mass in the C600 peak (Fig. 4) . Further purification and direct protein characterization will be required to define the nature of each complex, including whether one or more particular species is present in each of the C300 and C600 peaks. The data are consistent with the possibility that some combinations of SSIIa, SSI, BEIIa, and BEIIb associate to form C300, and this complex is joined by SSIII to form C600. In wheat endosperm, a 260-kD heteromeric complex has been observed in cross-linking studies between SSI, SSII, and either BEIIa or BEIIb (Tetlow et al., 2008) , in agreement with the elution profile described here for C300. Also of note is the fact that the relative distribution of each enzyme between its monomer form and high molecular mass form(s) varies. SSIII and SSIIa, for example, are predominantly found in a high molecular mass form as compared to the monomer (Fig. 4, rows 5-7) . To the contrary, the great majority of BEIIa is present as a monomer (Fig. 4, row 3) . BEIIb is apparently broadly Figure 8 . Coimmunoprecipitation of starch biosynthetic enzymes. A, Precipitation from total kernel soluble extracts using aBEIIa/b serum. The supernatant after immunoprecipitation and the eluted proteins were fractionated by SDS-PAGE and characterized by immunoblot analysis using the indicated antiserum. S lanes indicate the supernatant and P lanes indicate the precipitated proteins. B, Precipitation from total kernel soluble extracts using SS-specific antibodies. Details are as in A. C, Precipitation from amyloplast extracts using aSSIg. After extensive washing, the immunoprecipitated beads were boiled in SDS-PAGE loading buffer, and bound proteins were separated by 10% SDS-PAGE, transblotted, and immunodetected using the antisera indicated. These SDS-PAGE gels included 10% acrylamide. D, Precipitation from amyloplast extracts using aSSIIa (aS2). Details are as in C. 2, Mock precipitation without any serum exposed to the protein-A Sepharose.
distributed among different quaternary forms (Fig. 4 , rows 1 and 2), and BEI is exclusively present as a monomer under these conditions. Hydrophobic forces are likely to be important for association between components of the apparent complexes. Both the C600 and C300 complexes are stable in a chemical environment that energetically favors hydrophobic interactions (i.e. 1 M NaCl), and, furthermore, these conditions shift the distribution of BEIIa, BEIIb, and SSIIa toward C600 (Fig. 4, rows 2, 4, and 6 ). This observation does not obviously correspond with the fact that increasing salt concentration was used to break interactions and thus elute proteins from affinity columns. A potential explanation for the apparent anomaly is that both ionic interactions and hydrophobic effects are involved in associations within the complexes. The quaternary structures detected by GPC are preformed in the cell extracts, whereas new complexes with the column-bound ligand must form during affinity purification. Thus, different associations may be detected by the two methods, and ionic bonds and hydrophobic effects may vary in significance in each instance.
Hydrophobic interactions in quaternary structure might also be unexpected for proteins well known to function independently as enzymes, which is the case for all of the proteins examined in this study. Surface hydrophobicity interactions are known for enzymes with the same structural fold as the BEs, specifically the broadly conserved a-(1/4) glucan hydrolase family of a-amylases. These enzymes catalyze the same reaction as the BEs, with the distinction that in the latter instance, the cleaved glucan chain is transferred to a C-6 hydroxyl group, whereas the a-amylases utilize a free hydroxyl. Association of the glucan chain substrate with a-amylases is mediated in part by hydrophobic interactions on the surface of the enzyme, at noncatalytic sites (Bozonnet et al., 2007, and refs. therein) . Structural interactions of the same type might be involved in assembly of the BEs, and by extension the SSs, into the complexes present in the C300 and C600 fractions.
BEI stands out from the other five enzymes tested by its appearance exclusively as a monomer in the GPC analysis. One physical interaction involving BEI was detected, specifically its coimmunoprecipitation with SSI (Fig. 8C) . Again, different assembly states may be observed by immunoprecipitation and GPC. In analyses of wheat amyloplast proteins, BEI was detected as a component of a high molecular mass complex also containing starch phosphorylase and BEIIb . Further experimental analyses will be required to resolve the protein-binding capabilities of BEI in maize.
Specificity of Interaction
The observed specificity of interactions between the SSs and BEs rules out the trivial explanation that the proteins may simply stick to each other in cell extracts through random or glucan-mediated association. In particular, the data reveal interactions between SSI and both BEIIa and BEIIb; however, no direct association between the two BEs was detected in the immunoprecipitation or affinity purification analyses. Thus, BEIIa and BEIIb from the cell extracts are both competent to join complexes, but they do not do so with each other. Furthermore, a structurally and functionally similar enzyme, BEI, was not observed to be present in any of the complexes demonstrated by GPC (Fig. 4, row 8 ). This degree of specificity argues against a general adhesion among the proteins as the explanation for the observed associations. This certainly applies for all of the complexes observed with BEIIa or BEIIb and by extension is likely the case for the SSs as well.
Further evidence for specificity in starch biosynthetic enzyme associations is provided from the analysis of wheat endosperm presented in the accompanying article (Tetlow et al., 2008) . Associations between SSI, SSIIa, and BEIIa or BEIIb were observed in tissue harvested at mid-developmental stages but not at earlier stages, even though the enzymes are present and glucan synthesis is proceeding. Thus, some aspect of cell physiology affects whether or not the complexes can form, indicative of in vivo functions. Observation of complex formation in yeast nuclei, in particular between SSI and BEIIa or SSI and SSIII, also supports direct interactions between the binding partners, because in this instance there are no other maize factors present. Finally, pretreatment of the wheat amyloplast extracts with amyloglucosidase to remove glucan polymers had no effect on the observed immunoprecipita- a ''A'' indicates that antibodies specific for the first member of the binding pair were used as the precipitating agent, and ''B'' indicates that antibodies specific for the second member were used for precipitation. b ''A'' indicates that the first member of the binding pair was the solid phase ligand, and ''B'' indicates the second member was in the solid phase.
c ''A'' indicates that the first listed member of the binding pair was fused to GAL4-AD, and ''B'' indicates the second member was fused to GAL4-AD. tions (Tetlow et al., 2008) , contrary to what would be predicted if the SS and BE enzymes were associated nonspecifically through a common polymeric substrate.
Potential Functions
The long amino terminal extension of SSIII beyond the catalytic domain could serve as a scaffolding protein that brings together multiple components of the starch biosynthetic pathway. Part of this region is highly conserved among the chlorophytes (Ral et al., 2004, and refs. therein) , specifically the region referred to as SSIIIHD, and all known plant SSIII isoforms contain a further extension toward the amino terminus beyond this central conserved region (Fig. 2) . The data presented here indicate that the amino terminal domain specific to maize endosperm SSIII, as well as the central SSIIIHD region, each bind to different components of the starch biosynthetic pathway (Fig. 2) . Specifically, in vivo protein-protein interaction test data indicate that the amino terminal portion of SSIII in the first 181 residues can bind to BEIIa, whereas the SSIIIHD domain contained within residues 760 to 1,438 binds to SSI ( Fig. 1; Table I ). There may be two distinct BEIIa binding domains, because residues 366 to 648 of SSIII also bind to BEIIa in yeast nuclei. Likewise, there may be two domains of SSIII that bind to SSI, because in addition to the SSI-SSIIIHD interaction, the amino terminal fragment from residues 1 to 367 also interacts with SSI in yeast (Fig. 2) . Whether these multiple binding interactions of SSIII are physiologically significant remains to be determined; however, further analyses to investigate functions of the long, conserved amino terminal extension of the SSIII class of enzymes are warranted.
Suggested potential functions for the complexes include substrate channeling and/or effects on the crystallization of the linear chains of amylopectin to form crystalline lamellae. An intriguing consideration about starch biosynthesis is that the products of SSs are the substrates of BEs, and the products of BEs are the substrates of SSs. Thus, as opposed to random stochastic interactions between enzyme and substrate, biosynthesis of starch may occur while the growing polymer interacts simultaneously or near simultaneously with multiple biosynthetic enzymes. This consideration is complicated further by the presence of multiple classes of each enzyme, many of which are required for specific structural aspects of amylopectin. For example, mutations of SSI, SSII, or SSIII all cause specific and nonoverlapping structural defects in amylopectin (Zhang et al., 2004 (Zhang et al., , 2005 Delvalle et al., 2005; Fujita et al., 2007) . Association of the enzymes in complexes could provide an environment for ordered construction of the glucan polymer destined to crystallize and form starch granules. One possibility is that the space for crystallization is restricted by the presence of the enzymes in complexes. A second potential function is that organization of the enzymes in complexes could have direct effects on substrate binding and thus specific architectural consequences on amylopectin structure. For example, the position of a branch point might be determined by the spatial locations of an SS and BE active site relative to each other. These two proposed in vivo functions are not mutually exclusive.
Genetic data indicating regulatory interactions between SSs and BEs provide strong evidence to support the hypothesis that starch biosynthetic enzyme complexes are physiologically significant. For example, mutations in SSIII are known to result in increased SSI activity (Singletary et al., 1997; Cao et al., 1999) , and SSI and SSIII are shown here to be capable of associating in a multisubunit complex. The simplest explanation for the combined genetic and biochemical observations is that the two proteins function together in vivo in a complex and that this association confers a negative regulatory effect on SSI in wild-type kernels. These genetic indications of in vivo function are indirect, however, and numerous further experiments will be required to test for physiological significance of the observed complexes. Both in vivo crosslinking and in vivo BRET/FRET analyses can determine whether specific starch biosynthetic enzymes are located, in cells, within atomic distances of each other. Purification of the complexes present in the C300 and C600 peaks to homogeneity will be required to define the interactions. Effects of specific interactions on both SS and BE enzymatic activity can also be examined after purification. Further purification could also allow biophysical characterization to examine hydrophobicity effects on complex formation. Eventually, genetic modifications that prevent specific quaternary associations could be useful to further investigate potential physiological functions of any in vivo complex.
MATERIALS AND METHODS
Plant Materials
Maize (Zea mays) plants were field grown in the summer at Iowa State University and at Guelph University. Kernels from self-pollinated ears were collected at specified days after pollination, quickly frozen in liquid nitrogen, and stored at 280°C until use. Kernels of the maize inbred lines W64A and Oh43 were used to prepare endosperm whole cell soluble extracts or amyloplast extracts. All mutant alleles were backcrossed into the W64A inbred line. The following mutant alleles were utilized: ae1 (Maize Genetic Stock Center no. 517B), an uncharacterized mutation in the gene coding for BEIIb; su2-19791, an uncharacterized spontaneous mutation known to condition lack of SSII protein (Zhang et al., 2004) ; sbe1TMu, a Mutator transposon insertion in the gene coding for BEI (Blauth et al., 2002) ; sbe2aTMu, a Mutator transposon insertion in the gene coding for BEIIa (Blauth et al., 2001) ; ae-B, a 882-bp deletion in the gene coding for BEIIb that removes all of exon 9 (GenBank accession no. AF072725; Fisher et al., 1996 ; M. Yandeau-Nelson and M. Guiltinan, personal communication); and du1-M3, a Mutator insertion in the first exon of the gene coding for SSIII (M.G. James, unpublished data).
Recombinant Plasmids
Plasmids used to express hybrid proteins containing either the DNA binding domain or the transcriptional activation domain of yeast (Saccharomyces cerevisiae) GAL4, respectively, were constructed from the vectors pGAD-C or pGBD-C . In all instances, the GAL4 fragment was located at the amino terminus of the fusion protein. The maize portion of the fusion gene in plasmid pBEIIb-AD or pBEIIb-BD started at codon 62 of the full-length BEIIb open reading frame and terminated at the native stop codon at position 801. The source of the BEIIb cDNA sequence was plasmid pET23d-MBEII (Guan et al., 1994) . The maize portion of the fusion gene in plasmids pBEIIa-AD or pBEIIa-BD began at the codon known to correspond to the mature amino terminus of BEIIa protein as it exists in maize amyloplasts (Gao et al., 1997) and extended to the native termination codon following residue 794 of the mature protein. The source of the BEIIa cDNA sequence was a plasmid provided by Dr. M. Guiltinan (Pennsylvania State University). The maize portion of the fusion gene in plasmid pSSI-AD and pSSI-BD started at codon 40 of the full length SSI open reading frame and extended to the native stop codon at position 584. Four different portions of the amino terminus of SSIII were tested, and these amino acid spans are specified in the ''Results'' section. The source of the SSIII cDNA sequence was plasmid pMG10-6 (Gao et al., 1998) . Positive controls for the in vivo protein interaction assay were residues 84 to 708 of the SV40 large T antigen fused to the Gal4p transcriptional activation domain, and residues 72 to 390 of murine p53 fused to the Gal4p DNA binding domain (Li and Fields, 1993) . The vectors used to express the positive control proteins were pAD-GAL4-2.1 for the T antigen fragment and pBD-GAL4 for the p53 fragment (Stratagene).
Plasmid pHC16 was used for recombinant expression of maize BEIIa in Escherichia coli. pHC16 was built in the expression vector pET-29a(1) (Novagen) and contains the complete coding sequence of mature BEIIa, specifically amino acids 21 to 847 as specified by the available cDNA sequence (GenBank accession no. U65948). Amino acid 21 is known to be the mature amino acid terminus of BEIIa after cleavage of the targeting peptide during the import into the plastid (Fisher et al., 1993) . The BEIIa coding region is fused at the N terminus to the 15-amino acid S-tag coding sequence, and the gene fusion is expressed from the bacteriophage T7 promoter.
Plasmid pHC18 was used for recombinant expression of maize SSI in E. coli. Also built in pET-29a(1), this plasmid contains the complete coding sequence of mature SSI, specifically amino acids 39 to 670 according to the fulllength cDNA sequence (GenBank accession no. AAB99957). Amino acid 39 was directly identified as the mature N terminus by amino acid sequence of the purified protein . The recombinant SSI protein is fused to the S-tag sequence at its amino terminus.
Plasmid pTB-3829 was used to express SSIII residues 770 to 1,225 fused to glutathione S-transferase (GST) at the amino terminus. A fragment of the SSIII cDNA sequence was produced by PCR from plasmid pMG10-6 (Gao et al., 1998) . The downstream oligonucleotide primer included a stop codon following SSIII codon 1,225, and the upstream primer included a six-amino acid coding sequence providing a thrombin cleavage site immediately upstream of SSIII codon 770. The primers also contained the sequences required for in vitro recombination into plasmid vector pDONR221, using BP clonase of the Gateway cloning system (Invitrogen). This recombination generated the plasmid pTB-3828, which was confirmed by restriction mapping and determining the DNA sequence of the complete SSIII coding region as well as parts of the vector. In the second step, a segment of pTB-3828 was inserted into pDEST15 (Invitrogen) using the LR clonase of the Gateway system to produce the plasmid pTB-3829. The relevant expression construct within pTB-3829 contains the following elements: (1) the phage T7 promoter, inducible with isopropylthio-b-galactoside (IPTG); (2) a ribosome binding site sequence and a start codon; (3) a coding region for 223 amino acids of Schistosoma japonicum GST; (4) a linker sequence from the acceptor plasmid; (5) codons specifying the designed thrombin cleavage site; (6) SSIII codons 770 to 1,225; (7) a stop codon; and (8) a transcriptional termination sequence.
In Vivo Protein-Protein Interaction Tests
Standard methods and growth media were used for transformation and culturing of yeast (Ausubel et al., 1989) . The yeast strain PJ69-4A was used as the reporter for in vivo protein-protein interactions . The genotype of PJ69-4A is MATa ura3 his3 leu2 trp1 ade2 gal4 gal80 GAL2-ADE2 met2TGAL7-lacZ. Pairs of recombinant plasmids built in either the pGAD-C or pGBD-C vectors were cotransformed into PJ69-4A. Multiple independent transformants were selected that contained both the LEU2 and TRP1 markers of the two plasmids, respectively, and these clones were single colony purified. Cells were maintained on selective minimal medium lacking Leu and Trp, and then spread very lightly onto selective minimal test medium lacking Ade, Leu, and Trp. Growth of the colonies on the 2Ade medium indicated the two proteins being tested interact in the yeast nucleus to regenerate a GAL4 activity. Qualitative assay of b-galactosidase activity in permeabilized yeast colonies on filter lifts was as described (Ausubel et al., 1989) .
Recombinant Protein Expression and Purification
Recombinant BEIIa and SSI were expressed in E. coli and purified as follows. Host strain BL21DE3 transformed with expression plasmid pHC16 or pHC18 was grown in Luria-Bertani medium containing 30 mg/mL kanamycin to mid log phase in 400-mL cultures in 2-L flasks. Expression was induced by the addition of 1 mM IPTG, and cultures were shaken at room temperature for an additional 16 to 20 h. Cell pellets were washed and suspended in 10 mL sonication buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM dithiothreitol [DTT] , 0.1% Triton X-100, 1 mM phenylmethylsulfonyl fluoride [PMSF] ) and lysed by treatment with 100 mg/mL lysozyme followed by sonication. Lysates were centrifuged at 20,000 rpm for 20 min and the supernatant was collected. Recombinant SSI or BEIIa in the lysates was bound to S-protein-agarose through the high affinity S-tag:S-protein interaction according to the manufacturer's protocol (Novagen catalog no. 69704-4). To purify BEIIa for use as antigen, biotinylated thrombin was used to cleave the fusion protein and release it from the matrix, and streptavidin-agarose was used to remove the protease, as described by the manufacturer (Novagen catalog no. 69022-3).
Recombinant SSIIIHD was expressed in E. coli and purified as follows. pTB-3829 was transformed into host strain RosettaDE3pLysS (Novagen). Expression cultures in Luria-Bertani medium supplemented with 50 mg/mL carbenicillin (Sigma; 1 L in 2-L flasks) were inoculated from overnight precultures at a dilution of 1/100 and shaken vigorously for 2 h at 37°C. IPTG was then added to a final concentration of 0.5 mM, and the cultures were grown for an additional 4 h at 30°C. Cells were collected by centrifugation, washed in water, suspended in 20 mL of binding/wash buffer (20 mM TrisHCl, pH 7.5, 150 mM NaCl, 0.1% Triton X-100, 5 mM DTT) supplemented before use with 1 mM PMSF and 0.1 mg/mL lysozyme (Sigma), then incubated at 30°C for 15 min. The cell suspension was sonicated on ice with six bursts of 20 s each, then centrifuged at 17,000 rpm at 4°C for 20 min. The supernatant was filtered through a 0.45-mm nitrocellulose filter, and additional DTT was added to make the final concentration 10 mM. The GST-SSIIIHD fusion protein was purified from this lysate using glutathione-Sepharose 4B (GE Healthcare) according to the manufacturer's protocol. The bound protein on the affinity matrix was washed with 20 bed volumes of 13 binding/wash buffer, 5 bed volumes of 50 mM Tris-acetate, pH 7.5, 1 M KCl, then another 10 bed volumes of 13 binding/wash buffer.
The GST-SSIIIHD fusion protein was eluted from the matrix in one bed volume of 0.3% (w/v) reduced glutathione in 50 mM Tris-HCl, pH 8.0, during a 10-min incubation at room temperature with gentle rocking. After brief centrifugation, the supernatant was collected. The elution procedure was then repeated twice on the same beads, and the three supernatants were pooled. The GST region was separated from SSIIIHD by cleavage with biotinylated thrombin (Novagen) at 3 units/mL during a 16-h incubation at 4°C with gentle rocking. Biotinylated thrombin was removed by addition of streptavidinagarose (Novagen) according to the manufacturer's instructions, and cleaved GST was removed by addition of an excess of glutathione-Sepharose. The mixture was rocked for 1 h at room temperature and then centrifuged, and the supernatant containing purified recombinant SSIIIHD was collected and stored at 280°C.
Generation of Antisera
The polyclonal antiserum aBEIIa/b was generated in rabbits using purified recombinant BEIIa as the antigen. Initial immunizations were with 0.5 mg of antigen in 2 mL of 50% Freund's complete adjuvant (Sigma catalog no. F-5506). Subsequent booster injections containing 0.25 to 0.5 mg of recombinant BEIIa emulsified in Freund's incomplete adjuvant (Sigma catalog no. F-5881) were administered three times at 2-week intervals, and serum was harvested 2 weeks after the final injection. Serum prepared from the final bleed is referred to as aBEIIa/b. Preimmune serum was collected prior to the first injection to serve as a negative control.
Synthetic peptide fragments of BEI were chemically synthesized and used as antigen in rabbits to elicit antiserum aBEI. Two peptides of 20 amino acids each were chosen, specifically, residues 762 to 781 (YRVDEAGAGRRLHA-KAETGK) and residues 798 to 817 (KEDKEATAGGK-KGWFARQP) of the full-length sequence numbered according to GenBank accession number AAA82735. These sequences are located in the C-terminal extension of BEI that is not represented in the amino acid sequence of BEIIa or BEIIb. The synthetic peptides were synthesized as multiple antigenic peptide conjugates. The initial and booster injections included 0.5 mg of a mixture of the two peptides in 0.5 mL of PBS. Equal volume of Freund's complete adjuvant was used for the initial injection and Freund's incomplete adjuvant for the booster injections. The immunization schedule was the same as that used to immunize with recombinant BEIIa. Serum prepared from the final bleed is referred to as aBEI. Preimmune serum was again collected prior to the first injection to serve as a negative control.
Additional antisera targeted to SSI, SSIIa, BEI, BEIIa, and BEIIb were also raised against synthetic peptides. These sera are referred to as aSSIg, aSSIIa, aBEIg, aBEIIa, and aBEIIb, respectively. The specific peptide sequences used were as follows: SSI, AEPTGEPASTPPPVPD, corresponding to residues 72 to 87 of the full-length sequence (GenBank accession no. AAB99957); SSIIa, GKDAPPERSGDAARLPRARRN, corresponding to residues 69 to 89 of the full-length sequence (GenBank accession no. AAD13341); BEIIa, FRGHLDYR-YSEYKRLR, corresponding to residues 142 to 157 of the full-length sequence (GenBank accession no. AAB67316); BEIIb, PRGPQRLPSGKFIPGN, corresponding to residues 641 to 656 of the full-length sequence (GenBank accession no. AAC33764); and BEI, KGWKFARQPSDQDTK, corresponding to residues 809 to 823 of the full-length protein (GenBank accession no. AAC36471). These five polyclonal rabbit antisera were prepared commercially (http://www.anaspec.com/services/antibody.asp). Finally, the serum aSSI, raised against recombinant SSI and thus distinct from the anti-peptide serum aSSIg, has been described previously (Imparl-Radosevich et al., 1998) .
Three different antibody preparations that recognize SSIII were utilized in this study. The polyclonal rabbit antisera aDU1N, raised against the amino terminal 646 residues of maize SSIII, and aDU1F, raised against full-length SSIII, have been described previously (Cao et al., 1999) . In addition, the affinity purified IgG fraction termed aSSIIIHDP was prepared as follows. Affinity purified SSIIIHD (described in the preceding section) was dialyzed into 13 coupling buffer (0.1 M NaPO 4 buffer, pH 6.0, 5 mM EDTA). DTT was then added to a final concentration of 20 mM, and the solution was incubated for 1 h at room temperature. DTT was removed by passing the protein through a desalting column equilibrated in 13 coupling buffer. The protein was then covalently linked by disulfide bonds to SulfoLink Coupling Gel resin (Pierce) according to the manufacturer's instructions. Briefly, the protein solution was incubated with the resin (1-mL bed volume, approximately 0.5 mg protein in 1 mL coupling buffer), after which free sulfhydryls on the resin were blocked by incubation with 50 mM Cys. The affinity resin was washed with 1 M NaCl, then equilibrated by extensive washing in PBS.
Crude aDU1F serum (2 mL) was applied to the SSIIIHD-Sulfolink column, and the mixture was incubated at room temperature for 1 h. The flow through was collected, then passed through the column a second time. After extensive washing with PBS, bound IgG molecules were eluted in 0.2 M Gly-HCl, pH 3.0. Fractions containing protein were pooled and neutralized by addition of 1/20th volume of 1 M Tris-HCl, pH 8.5. The resulting IgG fraction, designated as aSSIIIHDP, was stored at 220°C until further use.
Whole Cell Kernel Extracts and Amyloplast Extracts
Whole cell soluble kernel extracts used for immunoprecipitation were prepared as follows. Maize kernels harvested 20 DAP were quick-frozen in liquid nitrogen and stored at -80°C until use. Approximately 10 g of frozen kernels were ground into a fine powder in a chilled mortar and pestle under liquid nitrogen. Ground tissues were mixed with homogenization buffer (HB; 50 mM Tris-acetate, pH 7.5, 10 mM EDTA, 2.5 mM DTT, 0.1 mM PMSF, 13 protease inhibitor cocktail [Sigma catalog no. P-2714]) at the ratio of 1 mL/g kernel weight. The mixture was allowed to stand for approximately 5 min on ice and was then centrifuged at 20,000 rpm for 20 min at 4°C. The supernatant, referred to as crude soluble extract, was kept on ice until further analysis.
Whole cell soluble kernel extracts used for affinity chromatography were prepared by a modification of this procedure. In this instance, the extraction buffer was 50 mM Tris-acetate, pH 7.5, 100 mM KCl, 1 mM DTT, 1 mM PMSF, 0.15% Tween 20, 13 protease inhibitor cocktail, and the kernels were ground directly in buffer instead of under liquid nitrogen.
Maize amyloplast extracts were prepared as follows by modification of a procedure previously used for wheat (Triticum aestivum) endosperm . Endosperm tissue extracted from fresh wild-type kernels harvested 16 DAP was suspended in ice-cold amyloplast extraction buffer (50 mM HEPES-KOH, pH 7.5, 0.8 M sorbitol, 1 mM EDTA, 1 mM KCl, 2 mM MgCl 2 ) and finely minced to homogeneity with a razor blade. The slurry was filtered through Miracloth (CalBiochem catalog no. 475855) and layered over 3% Histodenz (Sigma catalog no. D2158) in amylopast extraction buffer at approximately equal volumes. The lysates were centrifuged at 100g at 4°C for 20 min and the supernatant was carefully decanted. The starch pellet with a yellow ring of amyloplast fraction on top was suspended in ice-cold rupture buffer (100 mM Tricine-KOH, pH 7.8, 1 mM EDTA, 1 mM DTT, 5 mM MgCl 2 , 13 plant protease inhibitor cocktail; Sigma catalog no. P9599). The suspension was centrifuged at 5,000 rpm at 4°C for 5 min. The supernatant was collected and centrifuged again at 50,000 rpm at 4°C for 30 min. The supernatant was collected as the enriched amyloplast lysate and used directly for affinity purification, immunoprecipitation, and GPC analyses.
GPC
GPC fractionation of amyloplast extracts was performed at 4°C using a Superdex 10/300 GL column (GE Healthcare, catalog no. 17-5175-01) and an AKTA FPLC system. The column was equilibrated and run in 50 mM sodium phosphate buffer, pH 7.0, 1 mM DTT, containing either 150 mM NaCl or 1 M NaCl. The flow rate was 0.5 mL/min and fraction size was 0.4 mL. Amyloplast extracts were loaded in a volume of 0.5 mL containing approximately 2 mg total protein. Molecular mass standards run in identical conditions were from Bio-Rad (catalog no. 151-1901) . Samples from each fraction (30 mL) were analyzed by SDS-PAGE and immunoblotting.
SDS-PAGE and Immunoblot Analysis
Proteins were separated by two different SDS-PAGE conditions. Unless otherwise noted, the separation used standard Laemmli buffer conditions and 8% acrylamide gels (29:1 acrylamide:bisacrylamide; Bio-Rad catalog no. 161-0156; Ausubel et al., 1989) . In other instances, the Laemmli gels contained 10% acrylamide. In still other instances, SDS-PAGE utilized NuPAGE 4% to 12% gradient gels run in MOPS buffer at pH 7.7 (Invitrogen catalog nos. NP0343 and NP0001). Transfer of proteins from SDS gels to nitrocellulose membranes and probing with polyclonal antisera was performed according to standard protocols (Ausubel et al., 1989) . Immunoblot signals were detected using the ECL chemiluminescence detection system (GE Healthcare catalog no. RPN2209) and donkey anti-rabbit IgG horseradish peroxidase-conjugated secondary antibody (GE Healthcare catalog no. NA9340) or colorimetric detection using alkaline-phosphatase conjugated to the goat anti-rabbit IgG as the secondary antibody (Bio-Rad catalog no. 170-6432).
Affinity Chromatography
BSA was covalently coupled to Affi-Gel 10 (Bio-Rad catalog no. 153-6099) and precolumns were prepared as previously described (Kellogg et al., 1995) . S-protein agarose beads bound to recombinant SSI or BEIIa were generated as described in the previous section on recombinant protein expression. The bed volume of both the BSA precolumn and the affinity column was approximately 1 mL.
The precolumn and affinity column were equilibrated in 5 to 10 volumes of washing buffer (50 mM Tris-acetate, pH 7.5, 100 mM KCl, 1 mM DTT, 0.05% Tween 20, 10% glycerol) prior to loading the samples. Approximately 30 mg of cell lysate (approximately 3 mL) was loaded onto the BSA precolumn. The two columns were vertically connected so that the eluate from the precolumn passed directly to the affinity column. Solutions were passed through the columns by gravity flow. The affinity column was washed with five bed volumes (5 mL) of washing buffer while collecting 1-mL aliquots. Five successive 1-mL elution volumes of increasing salt concentration were then applied to the affinity column and the run-through fractions from each were collected. The elution buffers contained 50 mM Tris-acetate, pH 7.5, 1 mM DTT, and KCl at concentrations of 0.2 M, 0.4 M, 0.6 M, 0.8 M, and 1.0 M, respectively. Fractions were concentrated and desalted by centrifugal ultrafiltration. Concentrated protein solutions were dried in a SpeedVac and dissolved in 20 mL of 13 SDS-PAGE sample buffer. SDS-PAGE and immunoblot analysis was performed according to standard procedures (Ausubel et al., 1989) .
In an alternative method, recombinant SSI or BEIIa bound to 120 mL S-protein agarose was incubated at room temperature for 1 h with amyloplast soluble extracts purified from wild-type maize endosperm. The beads were packed into a Bio-Rad Polyprep chromatography column and washed with 250 mL, 150 mM NaCl in PBS to remove nonspecifically bound proteins. The agarose bead pellet was then boiled in SDS-PAGE sample buffer, and the eluted proteins were analyzed by SDS-PAGE and immunoblotting.
